1. Peripheral artery disease and osteoporosis: Not only age‑related (Review)
   Agostino Gaudio et al, 2018, Molecular Medicine Reports CrossRef
2. Imbalance of Pro- and Anti-Angiogenic Factors Due to Maternal Vitamin D Deficiency Causes Renal Microvasculature Alterations Affecting the Adult Kidney Function
   Lucas Ferreira de Almeida et al, 2019, Nutrients CrossRef
3. Sclerostin and Vascular Pathophysiology
   Antonino Catalano et al, 2020, International Journal of Molecular Sciences CrossRef
4. Early vascular ageing biomarkers in osteoporotic outpatients: a pilot study
   Agostino Gaudio et al, 2020, Scientific Reports CrossRef
5. Common mechanisms and holistic care in atherosclerosis and osteoporosis
   Zoltán Szekanecz et al, 2019, Arthritis Research & Therapy CrossRef
6. Synergistic effect of sclerostin and angiotensin II receptor 1 polymorphism on arterial stiffening
   Otto Mayer et al, 2020, Biomarkers in Medicine CrossRef
7. Roles of bone-derived hormones in type 2 diabetes and cardiovascular pathophysiology
   Xuzhu Lin et al, 2020, Molecular Metabolism CrossRef
8. Sclerostin is expressed in the atherosclerotic plaques of patients who undergoing carotid endarterectomy
   Gaetano Leto et al, 2019, Diabetes/Metabolism Research and Reviews CrossRef
9. Increased Sclerostin, but Not Dickkopf-1 Protein, Is Associated with Elevated Pulse Wave Velocity in Hemodialysis Subjects
   Eirini Stavrinou et al, 2019, Kidney and Blood Pressure Research CrossRef
10. Bone Health in Patients with Dyslipidemias: An Underestimated Aspect
    Panagiotis Anagnostis et al, 2022, International Journal of Molecular Sciences CrossRef
11. Hematological Diseases and Osteoporosis
    Agostino Gaudio et al, 2020, International Journal of Molecular Sciences CrossRef
12. Novel cardiovascular risk biomarkers in carotid atherogenesis
    Federico Carbone et al, 2018, Biomarkers in Medicine CrossRef
13. The Impact of Sclerostin Levels on Long-Term Prognosis in Patients Undergoing Coronary Angiography: A Personalized Approach with 9-Year Follow-Up
    Adam Kern et al, 2021, Journal of Personalized Medicine CrossRef
14. Cardiovascular Outcomes of Romosozumab and Protective Role of Alendronate
    Kamyar Asadipooya et al, 2019, Arteriosclerosis, Thrombosis, and Vascular Biology CrossRef
15. Sost Haploinsufficiency Provokes Peracute Lethal Cardiac Tamponade without Rescuing the Osteopenia in a Mouse Model of Excess Glucocorticoids
    Behzad Javaheri et al, 2019, The American Journal of Pathology CrossRef
16. Sclerostin within the chronic kidney disease spectrum
    Antoine Bouquegneau et al, 2020, Clinica Chimica Acta CrossRef
17. Sclerostin as a biomarker of cardiovascular risk in women with systemic lupus erythematosus
    Carlos Garcia-de los Ríos et al, 2022, Scientific Reports CrossRef
18. Mechanisms of Bone Fragility: From Osteogenesis Imperfecta to Secondary Osteoporosis
    Ahmed El-Gazzar et al, 2021, International Journal of Molecular Sciences CrossRef
19. Role of Sclerostin in Cardiovascular Disease
    Jonathan Golledge et al, 2022, Arteriosclerosis, Thrombosis, and Vascular Biology CrossRef
20. Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients
    Yu-Chi Chang et al, 2018, BMC Cardiovascular Disorders CrossRef
21. Arterial Stiffness and the Canonical WNT/β-catenin Pathway
    Alexandre Vallée, 2022, Current Hypertension Reports CrossRef
22. Wnt Pathway Gene Expression Is Associated With Arterial Stiffness
    Allison L. Kuipers et al, 2020, Journal of the American Heart Association CrossRef
23. Serum Sclerostin Is Associated with Peripheral and Central Systolic Blood Pressure in Pediatric Patients with Primary Hypertension
    Piotr Skrzypczyk et al, 2021, Journal of Clinical Medicine CrossRef